Analgesics in Guatemala
Description
Analgesics in Guatemala is expected to register moderate current value growth in 2025. During the review period, Guatemala has faced significant dengue outbreaks, exacerbated by heavy rainfall and increased mosquito transmission. Prior to confirming symptoms as those of dengue or other arboviruses, individuals are advised against using aspirin for treating fever, aches, and related symptoms. As consumer awareness about these distinctions grows, there has been a noticeable decline in aspirin use.
Euromonitor International's Analgesics in Guatemala report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International's Analgesics in Guatemala report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
22 Pages
- Analgesics in Guatemala
- Euromonitor International
- September 2025
- List Of Contents And Tables
- ANALGESICS IN GUATEMALA
- KEY DATA FINDINGS
- 2025 DEVELOPMENTS
- Acetaminophen benefits from dengue outbreaks
- Bayer continues to lead, but loses value share
- Small local grocers dominate distribution
- PROSPECTS AND OPPORTUNITIES
- Generics and topical analgesics with a natural positioning drive growth
- Guatemala strengthens its role as a regional hub for generic pharma innovation and distribution
- Increasing focus on a greener approach
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2020-2025
- Table 2 Sales of Analgesics by Category: % Value Growth 2020-2025
- Table 3 NBO Company Shares of Analgesics: % Value 2021-2025
- Table 4 LBN Brand Shares of Analgesics: % Value 2022-2025
- Table 5 Forecast Sales of Analgesics by Category: Value 2025-2030
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2025-2030
- CONSUMER HEALTH IN GUATEMALA
- EXECUTIVE SUMMARY
- Consumer Health in 2025: The big picture
- Key trends in 2025
- Competitive landscape
- Channel developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2020-2025
- Table 8 Life Expectancy at Birth 2020-2025
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2020-2025
- Table 10 Sales of Consumer Health by Category: % Value Growth 2020-2025
- Table 11 NBO Company Shares of Consumer Health: % Value 2021-2025
- Table 12 LBN Brand Shares of Consumer Health: % Value 2022-2025
- Table 13 Penetration of Private Label by Category: % Value 2020-2025
- Table 14 Distribution of Consumer Health by Format: % Value 2020-2025
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2025
- Table 16 Forecast Sales of Consumer Health by Category: Value 2025-2030
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
